Diversified Healthcare Analyst Ratings
Diversified Healthcare Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/05/2023 | 71.1% | B. Riley Securities | $4 → $4.5 | Maintains | Buy |
12/30/2021 | 128.14% | B. Riley Securities | $5 → $6 | Maintains | Buy |
07/29/2021 | 80.61% | Morgan Stanley | $5 → $4.75 | Maintains | Equal-Weight |
03/15/2021 | 90.11% | Morgan Stanley | $4.75 → $5 | Maintains | Equal-Weight |
02/02/2021 | 80.61% | Morgan Stanley | $5 → $4.75 | Maintains | Equal-Weight |
11/16/2020 | 23.57% | B of A Securities | $2.75 → $3.25 | Maintains | Underperform |
10/09/2020 | 14.07% | Morgan Stanley | $2.75 → $3 | Maintains | Equal-Weight |
06/22/2020 | 52.09% | Wells Fargo | $3.5 → $4 | Maintains | Equal-Weight |
06/08/2020 | — | JMP Securities | Reinstates | → Market Perform | |
05/19/2020 | 4.56% | Morgan Stanley | $8 → $2.75 | Maintains | Equal-Weight |
05/11/2020 | 166.16% | B. Riley Securities | $10 → $7 | Maintains | Buy |
03/04/2020 | 280.23% | B. Riley Securities | $12 → $10 | Maintains | Buy |
01/17/2020 | 242.21% | Wells Fargo | → $9 | Downgrades | Overweight → Equal-Weight |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
09/05/2023 | 71.1% | B. 萊利證券 | 4 美元 → 4.5 美元 | 維護 | 購買 |
12/30/2021 | 128.14% | B. 萊利證券 | 5 美元 → 6 美元 | 維護 | 購買 |
2021 年 7 月 29 日 | 80.61% | 摩根士丹利 | 5 美元 → 4.75 美元 | 維護 | 重量相等 |
2021 年 3 月 15 日 | 90.11% | 摩根士丹利 | 4.75 美元 → 5 美元 | 維護 | 重量相等 |
02/02/2021 | 80.61% | 摩根士丹利 | 5 美元 → 4.75 美元 | 維護 | 重量相等 |
11/16/2020 | 23.57% | B of A 類證券 | 2.75 美元 → 3.25 美元 | 維護 | 表現不佳 |
2020 年 9 月 10 日 | 14.07% | 摩根士丹利 | 2.75 美元 → 3 美元 | 維護 | 重量相等 |
2020 年 6 月 22 日 | 52.09% | 富國銀行 | 3.5 美元 → 4 美元 | 維護 | 重量相等 |
06/08/2020 | — | JMP 證券 | 恢復 | → 市場表現 | |
2020 年 5 月 19 日 | 4.56% | 摩根士丹利 | 8 美元 → 2.75 美元 | 維護 | 重量相等 |
05/11/2020 | 166.16% | B. 萊利證券 | 10 美元 → 7 美元 | 維護 | 購買 |
2020 年 4 月 3 日 | 280.23% | B. 萊利證券 | 12 美元 → 10 美元 | 維護 | 購買 |
2020 年 1 月 17 日 | 242.21% | 富國銀行 | → 9 美元 | 降級 | 超重 → 重量相等 |
What is the target price for Diversified Healthcare (DHC)?
多元化醫療保健(DHC)的目標價格是多少?
The latest price target for Diversified Healthcare (NASDAQ: DHC) was reported by B. Riley Securities on September 5, 2023. The analyst firm set a price target for $4.50 expecting DHC to rise to within 12 months (a possible 71.10% upside). 1 analyst firms have reported ratings in the last year.
B. Riley Securities於2023年9月5日公佈了多元化醫療保健(納斯達克股票代碼:DHC)的最新目標股價。該分析公司將目標股價定爲4.50美元,預計DHC將在12個月內上漲至71.10%(可能上漲71.10%)。去年有1家分析公司公佈了評級。
What is the most recent analyst rating for Diversified Healthcare (DHC)?
多元化醫療保健 (DHC) 的最新分析師評級是多少?
The latest analyst rating for Diversified Healthcare (NASDAQ: DHC) was provided by B. Riley Securities, and Diversified Healthcare maintained their buy rating.
多元化醫療(納斯達克股票代碼:DHC)的最新分析師評級由B. Riley Securities提供,多元化醫療維持買入評級。
When is the next analyst rating going to be posted or updated for Diversified Healthcare (DHC)?
多元化醫療保健 (DHC) 的下一份分析師評級何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Diversified Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Diversified Healthcare was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.
分析師在進行了廣泛的研究後得出了股票評級,包括閱讀公開財務報表、與多元化醫療的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級,因此每家公司每年應獲得4個評級。多元化醫療的最新評級是在2023年9月5日提交的,因此您應該預計下一個評級將在2024年9月5日左右公佈。
Is the Analyst Rating Diversified Healthcare (DHC) correct?
分析師對多元化醫療保健 (DHC) 的評級是否正確?
While ratings are subjective and will change, the latest Diversified Healthcare (DHC) rating was a maintained with a price target of $4.00 to $4.50. The current price Diversified Healthcare (DHC) is trading at is $2.63, which is out of the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但最新的多元化醫療保健(DHC)評級保持不變,目標股價爲4.00美元至4.50美元。多元化醫療保健(DHC)目前的交易價格爲2.63美元,超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。